Dr. Mohtashim Shamsi, Southern Illinois University, finalized his 2-year project with NDR. Shamsi investigated the feasibility of using label-free electrochemical detection methods to detect RAN and NfL in serum for patients with ALS. The proof-of-concept study facilitates a low cost point of care biosensing platform for clinical use. Future development of the graphene-modified low cost multiplexed wax-on-plastic biosensing chips include expanding the repertoire of ALS-associated proteins detected in the serum. The future of this technology is in stratifying patients in ALS studies to facilitate getting the right treatment to the right patient. We congratulate Dr. Shamsi on receiving a grant to continue his work on this important topic.
top of page
Recent PostsSee All
Indiana University researcher Chandler Walker, Ph.D., developed a stem cell-based secretome therapy that influences both the central and peripheral components of Amyotrophic Lateral Sclerosis (ALS) pa
The preprint manuscript Assessment of levamisole HCl and thymosin α1 in two mouse models of amyotrophic lateral sclerosis by David R Borchelt (Department of Neuroscience, University of Florida, Colle
NDR congratulates Dr. Chandler Walker, Associate Professor in the department of Biomedical Sciences and Comprehensive Care, Indiana University School of Dentistry, on the acceptance of his paper repor
bottom of page